The Efficacy and Tolerability of Pegylated Interferon-α-2a in Chronic Hepatitis B: A Multicenter Clinical Experience
Journal of Gastroenterology and Hepatology,

Ratnam D et al. – In everyday clinical practice Pegylated Interferon–α (PEG–IFN) therapy in chronic Hepatitis B (CHB) is well tolerated and can achieve a similar efficacy to that seen in large controlled trials.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Family Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Family Medicine Articles

Indexed Journals in Family Medicine: American Family Physician, Archives of Family Med, Annals of Family Medmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close